US Patent 9221843 Heteroaryl inhibitors of PDE4
Patent 9221843 was granted and assigned to Tetra Therapeutics on December, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+164 characters)
Article
Patent abstract
The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of disease.
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09221843 Heteroaryl inhibitors of PDE4 US Patent 9221843 Heteroaryl inhibitors of PDE4
Infobox
Patent Number
092218430
Patent Number
92218430
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
092218430
Date of Patent
December 29, 2015
0Patent Application Number
143496880
Date Filed
October 24, 2013
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09221843 Heteroaryl inhibitors of PDE4
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09221843
Date of patent
December 29, 2015
Patent application number
14349688
Date Filed
October 24, 2013
Patent primary examiner
Find more entities like US Patent 9221843 Heteroaryl inhibitors of PDE4
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.